Diagnosis and quantification of hepatic fibrosis in children with diffusion weighted MR imaging

Ahmed Abdel Khalek Abdel Razek1, Ahmed Abdalla, Eman Omran

  • 1Diagnostic Radiology Department, Mansoura Faculty of Medicine, 62 ElNokrasi Street Meet Hadr, Mansoura 3512, Egypt. arazek@mans.eun.eg

Insights

Diffusion weighted MRI accurately diagnoses and quantifies liver fibrosis in children with chronic hepatitis. The apparent diffusion coefficient (ADC) shows promise for non-invasive assessment of hepatic fibrosis severity.

Area of Science:

  • Pediatric Radiology
  • Hepatology
  • Medical Imaging

Background:

  • Chronic hepatitis in children can lead to significant liver fibrosis.
  • Accurate staging of hepatic fibrosis is crucial for treatment decisions.
  • Liver biopsy, the current gold standard, is invasive and carries risks.

Purpose of the Study:

  • To assess the diagnostic accuracy of diffusion-weighted magnetic resonance imaging (DW-MRI) for hepatic fibrosis in children.
  • To evaluate DW-MRI's ability to quantify the severity of liver fibrosis.
  • To correlate apparent diffusion coefficient (ADC) values with liver biopsy (METAVIR score).

Main Methods:

  • Sixty-three children with chronic hepatitis and 30 healthy volunteers underwent DW-MRI of the liver.
  • Liver biopsy was performed, and METAVIR fibrosis scores were calculated.
  • Apparent diffusion coefficient (ADC) values were measured and correlated with METAVIR scores.

Main Results:

  • Significant differences in mean ADC values were observed between healthy volunteers and children with fibrosis (P=0.001).
  • ADC values showed a strong correlation with METAVIR fibrosis scores (r=0.807, P=0.001).
  • A cutoff ADC value of 1.7×10⁻³ mm²/s demonstrated 83% accuracy in predicting fibrosis, with high sensitivity and specificity.

Conclusions:

  • Apparent diffusion coefficient (ADC) derived from DW-MRI is a reliable, non-invasive parameter for diagnosing and quantifying hepatic fibrosis in children.
  • DW-MRI offers a promising alternative to liver biopsy for assessing fibrosis severity in pediatric chronic hepatitis.
Abstract